{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:30:28Z","timestamp":1789914628133,"version":"4.0.1"},"reference-count":96,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry for Instruction, University and Research","award":["FFARB 2017"],"award-info":[{"award-number":["FFARB 2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is an incurable and fatal disorder characterized by the progressive loss of motor neurons in the cerebral cortex, brain stem, and spinal cord. Sporadic ALS form accounts for the majority of patients, but in 1\u201313.5% of cases the disease is inherited. The diagnosis of ALS is mainly based on clinical assessment and electrophysiological examinations with a history of symptom progression and is then made with a significant delay from symptom onset. Thus, the identification of biomarkers specific for ALS could be of a fundamental importance in the clinical practice. An ideal biomarker should display high specificity and sensitivity for discriminating ALS from control subjects and from ALS-mimics and other neurological diseases, and should then monitor disease progression within individual patients. microRNAs (miRNAs) are considered promising biomarkers for neurodegenerative diseases, since they are remarkably stable in human body fluids and can reflect physiological and pathological processes relevant for ALS. Here, we review the state of the art of miRNA biomarker identification for ALS in cerebrospinal fluid (CSF), blood and muscle tissue; we discuss advantages and disadvantages of different approaches, and underline the limits but also the great potential of this research for future practical applications.<\/jats:p>","DOI":"10.3390\/cells7110219","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T11:23:27Z","timestamp":1542799407000},"page":"219","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-0308","authenticated-orcid":false,"given":"Claudia","family":"Ricci","sequence":"first","affiliation":[{"name":"Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Marzocchi","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-7624","authenticated-orcid":false,"given":"Stefania","family":"Battistini","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature","volume":"41","author":"Logroscino","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","article-title":"Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues","volume":"79","author":"Logroscino","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/17482961003610853","article-title":"The sex ratio in amyotrophic lateral sclerosis: A population based study","volume":"11","author":"Manjaly","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/17482960802430799","article-title":"What we truly know about occupation as a risk factor for ALS: A critical and systematic review","volume":"10","author":"Sutedja","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11910-996-0008-9","article-title":"Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene","volume":"6","author":"Andersen","year":"2006","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/brain\/113.2.347","article-title":"Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy","volume":"113","author":"Hentati","year":"1990","journal-title":"Brain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical genetics of amyotrophic lateral sclerosis: What do we really know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1440-1789.2012.01332.x","article-title":"Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: Clinicopathologic correlation","volume":"33","author":"Bigio","year":"2013","journal-title":"Neuropathology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00018-013-1480-4","article-title":"Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis","volume":"71","author":"Rizzo","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_15","first-page":"252","article-title":"Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis","volume":"30","author":"Volk","year":"2018","journal-title":"Med. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1073\/pnas.1112427109","article-title":"TDP-43 promotes microRNA biogenesis as a component of the drosha and dicer complexes","volume":"109","author":"Kawahara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: Emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Polymenidou","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor. Neuron Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jocn.2004.04.011","article-title":"Riluzole therapy for motor neurone disease: An early Australian experience (1996\u20132002)","volume":"13","author":"Zoing","year":"2006","journal-title":"J. Clin. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/525097","article-title":"Blood biomarkers for amyotrophic lateral sclerosis: Myth or reality?","volume":"2014","author":"Robelin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microrna biogenesis, mechanisms of actions, and circulation","volume":"9","author":"Hayder","year":"2018","journal-title":"Front. Endocrinol. Lausanne"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of miRNA expression across human tissues","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/138955709787001802","article-title":"Oncomirs: From tumor biology to molecularly targeted anticancer strategies","volume":"9","author":"Mocellin","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbagrm.2008.04.008","article-title":"Roles of microRNAs beyond development\u2014metabolism and neural plasticity","volume":"1779","author":"Aumiller","year":"2008","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2009.01.008","article-title":"MicroRNAs: Novel regulators of immunity","volume":"8","author":"Carissimi","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.conb.2008.07.001","article-title":"MicroRNAs in neurodegeneration","volume":"18","author":"Bushati","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ncrna.2018.07.001","article-title":"Macro roles for microRNAs in neurodegenerative diseases","volume":"3","author":"Rajgor","year":"2018","journal-title":"Noncoding RNA Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s12035-017-0537-z","article-title":"MicroRNA Metabolism and dysregulation in amyotrophic lateral sclerosis","volume":"55","author":"Rinchetti","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids-the mix of hormones and biomarkers","volume":"8","author":"Cortez","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.7150\/jca.4919","article-title":"Cell-free circulating miRNA biomarkers in cancer","volume":"3","author":"Mo","year":"2012","journal-title":"J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fnmol.2013.00039","article-title":"MicroRNAs as biomarkers for CNS disease","volume":"6","author":"Rao","year":"2013","journal-title":"Front. Mol. Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"MiRNA malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.15252\/embj.201490493","article-title":"Dysregulated miRNA biogenesis downstream of cellular stress and als-causing mutations: A new mechanism for ALS","volume":"34","author":"Emde","year":"2015","journal-title":"EMBO J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2009.09.029","article-title":"The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)","volume":"288","author":"Strong","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1038\/emboj.2012.319","article-title":"FUS stimulates microRNA biogenesis by facilitating co-transcriptional drosha recruitment","volume":"31","author":"Morlando","year":"2012","journal-title":"EMBO J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00216-008-2570-2","article-title":"MicroRNA detection by microarray","volume":"394","author":"Li","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/genes1010070","article-title":"Next generation sequencing of miRNAs\u2013strategies, resources and methods","volume":"1","author":"Motameny","year":"2010","journal-title":"Genes"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nbt1394","article-title":"Discovering MicroRNAs from deep sequencing data using miRDeep","volume":"26","author":"Chen","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/bib\/bbp019","article-title":"Expression profiling of microRNAs by deep sequencing","volume":"10","author":"Creighton","year":"2009","journal-title":"Brief Bioinform."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/nar\/gkn725","article-title":"High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA","volume":"36","author":"Mestdagh","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/nar\/gnh040","article-title":"A high-throughput method to monitor the expression of microRNA precursors","volume":"32","author":"Schmittgen","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/14737159.9.2.187","article-title":"Reliability of real-time reverse-transcription PCR in clinical diagnostics: Gold standard or substandard?","volume":"9","author":"Murphy","year":"2009","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.clinbiochem.2013.02.017","article-title":"Detection methods for microRNAs in clinic practice","volume":"46","author":"Rodicio","year":"2013","journal-title":"Clin. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","article-title":"Data normalization strategies for microRNA quantification","volume":"61","author":"Schwarzenbach","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1261\/rna.939908","article-title":"Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues","volume":"14","author":"Peltier","year":"2008","journal-title":"RNA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","article-title":"A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"508","author":"Guida","year":"2012","journal-title":"Gene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_53","first-page":"365","article-title":"microRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)","volume":"3","author":"Alexandrov","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS","volume":"122","author":"Butovsky","year":"2012","journal-title":"J. Clin. Invest."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2051-5960-1-42","article-title":"Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis","volume":"1","author":"Freischmidt","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"MiR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients","volume":"15","author":"Annunziata","year":"2014","journal-title":"Neurogenetics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","article-title":"Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"18","author":"Benigni","year":"2016","journal-title":"Neuromolecular Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fnins.2017.00731","article-title":"Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity","volume":"11","author":"Waller","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era","volume":"11","author":"Sakowski","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1523\/JNEUROSCI.3582-16.2017","article-title":"MicroRNA profiling reveals marker of motor neuron disease in ALS models","volume":"37","author":"Hoye","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kos, A., Olde Loohuis, N.F., Wieczorek, M.L., Glennon, J.C., Martens, G.J., Kolk, S.M., and Aschrafi, A. (2012). A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinase. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031022"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1016\/j.febslet.2013.09.044","article-title":"miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a","volume":"587","author":"Chen","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11060-009-9797-4","article-title":"miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors","volume":"93","author":"Conti","year":"2009","journal-title":"J. Neurooncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-60761-938-3_4","article-title":"The blood-cerebrospinal fluid barrier: Structure and functional significance","volume":"686","author":"Johanson","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2015.07.027","article-title":"A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans","volume":"273","author":"Spector","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13311-016-0503-x","article-title":"Fluid-based biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Vu","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Toivonen, J.M., Manzano, R., Oliv\u00e1n, S., Zaragoza, P., Garc\u00eda-Redondo, A., and Osta, R. (2014). MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE., 9.","DOI":"10.1371\/journal.pone.0089065"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/brain\/awu249","article-title":"Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers","volume":"137","author":"Freischmidt","year":"2014","journal-title":"Brain"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2660.e15","DOI":"10.1016\/j.neurobiolaging.2015.06.003","article-title":"Serum microRNAs in sporadic amyotrophic lateral sclerosis","volume":"36","author":"Freischmidt","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13041-015-0161-7","article-title":"Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral Sclerosis","volume":"8","author":"Takahashi","year":"2015","journal-title":"Mol. Brain"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnmol.2016.00069","article-title":"Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"9","author":"Chen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","article-title":"MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis","volume":"368","author":"Avansini","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/NP300889","article-title":"circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS","volume":"35","author":"Tasca","year":"2016","journal-title":"Clin. Neuropathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","article-title":"Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mus.26106","article-title":"Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis","volume":"58","author":"Raheja","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","article-title":"Serum miRNAs miR-206, 143\u20133p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)","volume":"55","author":"Waller","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fnmol.2018.00106","article-title":"Differential expression of several miRNAs and the host genes AATK and DNM2 in leukocytes of sporadic ALS patients","volume":"11","author":"Vrabec","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.12.020","article-title":"Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis","volume":"64","author":"Matamala","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5582\/irdr.2017.01091","article-title":"Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients","volume":"7","author":"Xu","year":"2018","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","article-title":"Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis","volume":"11","author":"Liguori","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Taguchi, Y.H., and Wang, H. (2018). Exploring microRNA biomarker for amyotrophic lateral sclerosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051318"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.biocel.2012.08.007","article-title":"Exosomes: New players in cell-cell communication","volume":"44","author":"Bang","year":"2012","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1873-3468.12024","article-title":"Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression","volume":"590","author":"Cui","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_84","first-page":"239","article-title":"Mega roles of microRNAs in regulation of skeletal muscle health and disease","volume":"5","author":"Sharma","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7150\/ijbs.10921","article-title":"MiR-206, a key modulator of skeletal muscle development and disease","volume":"11","author":"Ma","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","article-title":"MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice","volume":"326","author":"Williams","year":"2009","journal-title":"Science"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bpa.12350","article-title":"The role of skeletal muscle in amyotrophic lateral sclerosis","volume":"26","author":"Loeffler","year":"2016","journal-title":"Brain Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2015.12.013","article-title":"Muscle-specific microRNAs in skeletal muscle development","volume":"410","author":"Horak","year":"2016","journal-title":"Dev. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Di Pietro, L., Lattanzi, W., and Bernardini, C. (2018). Skeletal muscle MicroRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051534"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/brain\/awt164","article-title":"Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression","volume":"136","author":"Bruneteau","year":"2013","journal-title":"Brain"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2012.08.015","article-title":"Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis","volume":"49","author":"Russell","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5930621","DOI":"10.1155\/2016\/5930621","article-title":"Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis","volume":"2016","author":"Jensen","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2017.07.008","article-title":"Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration","volume":"380","author":"Pegoraro","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2018.02.009","article-title":"Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis","volume":"114","author":"Si","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1038\/s41598-018-23139-2","article-title":"Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls","volume":"8","author":"Kovanda","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1038\/s41598-017-10161-z","article-title":"Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients","volume":"7","author":"Baranzini","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/7\/11\/219\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:58Z","timestamp":1760196658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/7\/11\/219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":96,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["cells7110219"],"URL":"https:\/\/doi.org\/10.3390\/cells7110219","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}